Teleflex Incorporated (TFX) exhibits 56.2% gross margins and 1.8% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 40.9x enterprise multiple and 4.8% implied options volatility.
Sustained 56.2% gross profitability converts into 5.9% operating margin and 1.8% ROIC, outpacing sector cost of capital.
ROIC: 1.8% // GM: 56.2%YoY revenue trajectory of +17.2% paired with -18.00% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +17.2% // FCF YLD: -18.00%Altman Z-Score of 2.12 and Piotroski F-Score of 4/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.12 // F-SCORE: 4/9Trading at 24.0x trailing P/E (27.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: 40.9xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $139.77 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend -45.4% net margins.
NET MARGIN: -45.4% // D/E: 0.81x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for TFX & activate live FRED threshold breach alerts.